Operationalising factors that explain the emergence of infectious diseases : a case study of the human campylobacteriosis epidemic by Strachan, Norval J C et al.
Operationalising Factors That Explain the Emergence of
Infectious Diseases: A Case Study of the Human
Campylobacteriosis Epidemic
Norval J. C. Strachan1, Ovidiu Rotariu1, Marion MacRae2, Samuel K. Sheppard3, Alison Smith-Palmer4,
John Cowden4, Martin C. J. Maiden5, Ken J. Forbes2*
1 Institute of Biological and Environmental Sciences, University of Aberdeen, Aberdeen, United Kingdom, 2 School of Medicine and Dentistry, University of Aberdeen,
Aberdeen, United Kingdom, 3Medical Microbiology and Infectious Diseases, Swansea University, College of Medicine, Swansea, United Kingdom, 4Health Protection
Scotland, National Services Scotland, Glasgow, United Kingdom, 5Department of Zoology, University of Oxford, Oxford, United Kingdom
Abstract
A framework of general factors for infectious disease emergence was made operational for Campylobacter utilising
explanatory variables including time series and risk factor data. These variables were generated using a combination of
empirical epidemiology, case-case and case-control studies, time series analysis, and microbial sub-typing (source
attribution, diversity, genetic distance) to unravel the changing/emerging aetiology of human campylobacteriosis. The
study focused on Scotland between 1990–2012 where there was a 75% increase in reported cases that included .300%
increase in the elderly and 50% decrease in young children. During this period there were three phases 1990–2000 a 75%
rise and a 20% fall to 2006, followed by a 19% resurgence. The rise coincided with expansions in the poultry industry,
consumption of chicken, and a shift from rural to urban cases. The post-2000 fall occurred across all groups apart from the
elderly and coincided with a drop of the prevalence of Campylobacter in chicken and a higher proportion of rural cases. The
increase in the elderly was associated with uptake of proton pump inhibitors. During the resurgence the increase was
predominantly in adults and the elderly, again there was increasing use of PPIs and high prevalences in chicken and
ruminants. Cases associated with foreign travel during the study also increased from 9% to a peak of 16% in 2006 before
falling to an estimated 10% in 2011, predominantly in adults and older children. During all three periods source attribution,
genetic distance, and diversity measurements placed human isolates most similar to those in chickens. A combination of
emergence factors generic for infectious diseases were responsible for the Campylobacter epidemic. It was possible to use
these to obtain a putative explanation for the changes in human disease and the potential to make an informed view of
how incidence rates may change in the future.
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Introduction
Emerging infectious diseases can be defined as ‘‘infections that
have newly appeared in a population or have existed but are
rapidly increasing in incidence or geographic range [1].’’ Most
emerging infectious diseases are of zoonotic origin and conse-
quently involve spill over from animal to human populations [2,3].
A number of factors can contribute to the emergence of an
infectious disease and these include (i) ecological changes
(including those due to economic development and agricultural
land use), (ii) human demographics, behaviour, (iii) international
travel and commerce (iv) technology and industry (v) microbial
adaptation/change and (vi) breakdown in public health measures
[1].
Campylobacter is recognised as the largest cause of bacterial
gastroenteritis in the developed world [4] with 70,973 cases
reported in the UK during 2011 [5,6], .220,000 in the EU [7]
and an estimated 850,000 foodborne domestically acquired cases
in the USA annually [8]. Since there is significant underreporting
the actual number of community cases is likely to be considerably
higher (e.g. estimated to be nine-fold higher in the UK [9]).
Further, around 10% of indivduals reported as having campylo-
bacteriosis are hospitalised and sequelae include not only severe
stomach cramps and diarrhoea but in up to two-thirds of cases
musculoskeletal, joint swelling or sensory problems [10]. In the
UK it has been reported that Campylobacter contributes to 15% of
all Guillain-Barre´ Syndrome cases [11] and .80 deaths annually
[12]. This all causes considerable demands on health services,
PLOS ONE | www.plosone.org 1 November 2013 | Volume 8 | Issue 11 | e79331
economic costs and impacts on those infected and their families
and carers.
Human Campylobacter infections may have been detected as far
back as 1880 in diarrhoeal infants in Germany [13]. However, it
was not until 1977 when Skirrow developed a routine plating
method that clinical microbiological labs were readily able to
isolate Campylobacter from stool samples [14]. In the UK
Campylobacter reports increased linearly during the 1980’s [15]
and this continued during the 1990’s until a peak was reached in
2000, then followed a decline to 2004/5 followed by a steady
increase to the current day [5]. However, this trend in human
infection is considerably complex with large increases in disease
incidence in the elderly reported over the last 20 years, whilst
incidence in young children has actually fallen [6,16]. It is
currently unclear which of the factors of emergence mentioned
above are driving this disease pattern.
Campylobacter is zoonotic and is found in a very wide range of
sources including farm and wild animals, birds and pets [13].
Cases are predominantly sporadic with few outbreaks and
secondary transmission in humans is rare [17]. The aetiology is
complex and identification of risk factors has traditionally been by
empirical and analytical epidemiology predominantly utilising case
control methodologies [18]. These risk factors denote the statistical
likelihood of being ill (or not ill) [19] and can either relate to the
‘‘source’’ (e.g food vehicle or host reservoir) or the ‘‘human
population’’ (e.g. age, gender, location etc.) [20]. However, a risk
factor approach has a number of weaknesses [21]. First, these risk
factors are usually more specific to the particular infectious disease
than the general factors for emergence listed above. Second, case-
control studies are usually conducted at a single time-point (or over
a relatively short period) and they do not provide information on
emergence of infectious disease over time. Third, the analyses
assume that populations are simple collections of individuals that
are independent (i.e. do not interact) [22].
A meta analysis [23] of case control studies on Campylobacter
from across the world found that international travel, followed by
consumption of undercooked chicken, environmental exposure
(drinking water, recreational water, contact with bird droppings)
and direct contact with farm animals (particularly associated with
young children) and pets were significant risk factors. Other
important factors included pre-existing chronic disease, eating
chicken in a restaurant, eating poultry and consuming unpasteur-
ized dairy products.
A case-control study in North-East Scotland [24] reported that
proton pump inhibitors (PPIs) (Odds ratio (OR) 2.4), overnight
stay outside study area (OR 2.03), contact with farm animals (OR
1.50), pets at home (OR 1.23), private water supply (OR 2.98),
barbeque and picnic (OR 1.47) and diving in the sea (OR 4.14)
were associated with disease whilst consumption of pre-packed
ready to eat foods was protective (0.60). Unfortunately, additional
risk factors such as preparing chicken from raw, consuming
undercooked chicken etc. were not collected in this study. There is
the potential to compare risk factor data (e.g. originating from case
control studies) over different time points. This could be done in a
case-case format with one time point being the reference. This
would enable identification of changes in risk factors over time but
this has yet to be attempted for human campylobacteriosis.
More recently with the advent of DNA sequence based typing
methods such as multi-locus sequence typing (MLST) it has been
possible to attribute human cases to source (either at the point of
reservoir or retail food level). MLST studies from north-west
England [25], Scotland [26] and New Zealand [27] have all
identified chicken as the main reservoir source of human disease
(50% to 80%) with the most common strains found in humans also
being the most common in retail chicken. These studies also
identified ruminants as an important reservoir source and further
epidemiological work demonstrated that this was particularly the
case for young children in rural areas [28] especially during the
spring peak of infection [29]. Source attribution (employing
microbial sub-typing) is again generally based on a single time
point (or short period) though dynamic temporal attribution is now
being reported as data become available [30].
It is now possible to integrate analytical epidemiological
methods and microbial sub-typing. For example Gras and
colleagues [31] combined risk factors from a case-control study
with MLST based source attribution data. They found that
consuming chicken was a risk factor for campylobacteriosis caused
by chicken associated genotypes. Also, that ruminant associated
genotypes were associated with occupational exposure to animals,
barbecueing in non-urban areas, consumption of tripe and never/
seldom consumption of chicken.
Another approach is to use the source attribution data in a case-
case format where for example there can be comparison between
chicken and non-chicken genotypes. This has been carried out for
C. jejuni [32] where cases attributed to poultry sources were
associated with adults, females, high population density areas, the
winter and foreign travel. For C. coli [33] cases associated with
poultry were also associated with being female. But again all of
these studies are considering the aetiology of human campylo-
bacteriosis at a single timepoint or over a short period.
To understand the pattern of disease emergence it is first
necessary to obtain the temporal dynamics of the factors that drive
this emergence [1]. Table 1 uses Morse’s emerging factors as a
framework on which to append specific examples for human
campylobacteriosis. To these, explanatory variables can be
assigned which include both risk factors from case control (or
case-case) studies and time series data. The aim of this paper is to
use Campylobacter as an exemplar infectious disease that has
emerged over the last 30 years to both evaluate the utility of this
framework as well as evaluating its explanatory power in
unravelling the mechanisms of disease emergence/re-emergence.
The study will focus on Scotland, particularly the north-east (i.e.
the Grampian region) where data sets are available over extended
time periods and where there is a considerable burden of disease.
Materials and Methods
Data
Clinical cases. In Scotland Campylobacter confirmed labora-
tory reports are notifiable (Health Protection Scotland. Available:
www.hps.scot.nhs.uk/publichealthact/Index.aspx. Accessed 2013
Oct 2.) and the weekly reported cases of human campylobacter-
iosis between the years 1990 and 2011 (n= 112,230) were obtained
from Health Protection Scotland (HPS). The collection of these
data is part of a national surveillance system, where diagnostic
laboratories throughout Scotland provide HPS with weekly reports
of detected infections. These data are stratified by regional health
board (n = 15 pre-2006, 14 afterwards) and into groups (young
children (0–4), children (5–14), adults (15–64) and the elderly
(65+). Subsets of human case reports (Grampian 1997–2010
totalling 10,247 cases and Scotland 2000–2006 totalling 34,947
cases) also included details of postal sector, gender and reporting
date. Isolates were further obtained from the following subsets of
human cases and genotyped by MLST (Grampian, 2001, n= 172;
Grampian 2005–2007, n= 1452 and Grampian 2010–2012,
n = 1292). Clinical case data were combined with human
population data (see below) to determine disease incidence.
The Emerging Campylobacter Epidemic
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Human population. Middle year population estimates
(1991–2011) at health board level stratified by 5 year age groups
and gender were obtained from the General Register Office for
Scotland (GROS. Available: www.gro-scotland.gov.uk. Accessed
2013 Oct 2.). In addition these data were acquired at postcode
sector level from the 2000 census.
Hospitalisation. The number of hospital episodes in Scottish
residents with a diagnosis of Campylobacter enteritis (ICD-10 code
A045) by calendar year (1997–2012, n= 7291) and stratified by
age was obtained from the Information Services Division (ISD),
National Health Services of Scotland, Edinburgh, UK.
Poultry industry and household purchases of
chicken. The number of chicks placed on commercial broiler
farms in the UK was obtained from DEFRA during 1993–2012
(GOV.UK. Available: www.gov.uk/government/publications/
poultry-and-poultry-meat-statistics. Accessed 2013 Oct 2.). The
average amount (kg) of poultry purchased by each household per
year from 1988 to 2012 was obtained from DEFRA’s Family Food
Survey (National Statistics. Available: https://statistics.defra.gov.uk/
esg/publications/efs/datasets/default.asp. Accessed 2013 Oct 2.).
Integration of case control data, foreign travel and PPI
time series datasets. Case-control data from north-east Scotland
gathered between 2005–2007 [24] were used to infer the incidence
of human campylobacteriosis in Scotland associated with foreign
travel and PPI risk factors (these risk factors were selected because
they had OR .1.5 and .15% of cases were exposed). Data on
foreign travel visits (1990–2011 obtained from the international
passenger survey, Transport Scotland. Available: http://www.
transportscotland.gov.uk/. Accessed 2013 Oct 2.) and PPI dispens-
ing rates (1993–2011 obtained from ISD, Edinburgh, UK) were
used to infer the incidence of human disease associated with these
risk factors during the study period.
Microbiology and Genotyping
Sampling retail chicken and animal hosts. Retail chicken
meat was sampled in 2001, 2005–07 and 2010–12 as described
previously [34]. Samples were collected from rural and urban
areas across north-east (Grampian) and also south west Scotland
(2005–07 only). A full list is in Table S1. In all cases fresh faceal
mammalian (25 g) and avian (,5 g) grab samples from the field
and abattoir were collected. Samples were transported chilled
(4uC) to the laboratory for immediate analysis [35].
Microbial isolation. The presence or absence of Campylo-
bacter was determined by homogenising faecal aliquots (10:90 w:v)
Table 1. Factors and explanatory variables for infectious disease emergence exemplified for human campylobacteriosis.
Emergence Factor Specific example for Campylobacter Explanatory variables
Time Series
Risk Factor (Case control or
Case-Case)
Ecological changes (including
those due to economic
development and agricultural
land use)
Intensification of on farm
chicken production
No. of chicks being placed
into production*
Human demographics,
behaviour
Ageing population Census statistics Campylobacteriosis
rate by age*
Age*
Rural/Urban population Census Statistics Campylobacteriosis
rate by rurality*
Rurality*
Deprivation Census statistics Campylobacteriosis
rate by deprivation index
Deprivation*
Chronic diseases Population use of PPI’s*
Hospitalisation*
Use of PPI’s*
Eating/drinking habits Consumption of chicken
(household)*
Consumption of undercooked
chicken, Eating chicken (at a
restaurant) Consumption of
unpasteurized dairy products BBQ &
Picnic Drinking from PWS
Interaction with domestic
animals, pets and wildlife
Contact with farm animals Contact
with pets Contact with birds
(droppings)
Recreation Recreational water, diving in sea
International travel
and commerce
Contracting disease
whilst on travels
International travel survey*
Domestic travel survey
Overnight stay outside home
International travel* National travel
(involving overnight stay outside of
home)
Technology and industry Modern food production
and processing
Prevalence/load on chicken after
slaughter and retail*
Microbial adaptation
and change
Change of genotypes in
humans and animals
Dynamic source attribution*,
Genetic distance*, Genetic diversity*,
Phylogenetic evolution*
Antibiotic resistance Surveillance over time
Breakdown in public-health
measures
Commercial Restaurant Outbreaks e.g. associated with chicken liver
paˆte´
*Variables used in the current study.
doi:10.1371/journal.pone.0079331.t001
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in Campylobacter enrichment broth (see below) microaerobically in
an atmosphere of 10% CO2, 5% O2, balance N2. Enrichment
broth comprised 100 mL volumes of nutrient broth base (Mast,
Bootle, United Kingdom) with 5% horse blood, growth supple-
ment (Mast Selectavial SV61), amphotericin (2 mg/mL), cefoper-
azone (15 mg/mL), and trimethoprim (10 mg/mL); polymixin B
(2500 IU/L) and rifampicin (5 mg/mL) were added, and the
broths incubated for 2 days at 37uC (Bull et al., 2006). All
antimicrobials were purchased from Sigma-Aldrich (United
Kingdom). Enrichment broths (0.1 mL) were plated onto modified
Campylobacter Blood-Free Selective Agar Base (CCDA base,
CM0739; Oxoid, United Kingdom) with CCDA selective
supplement (SR 155; Oxoid) incubated microaerobically for 2
days at 37uC (minimum detection level was therefore 0.1 cfu/g).
Genus and species confirmation. Genus confirmation of
Campylobacter spp. was achieved by Microscreen latex (Microgen,
Camberley, United Kingdom) agglutination test. Individual
colonies were stored (280uC, nutrient broth, glycerol added to
15% [v/v]). Bacterial DNA from latex test-positive isolates was
prepared using a DNA release method (Chelex resin; catalogue
no. 142-1253; Bio-Rad, United States). Campylobacter species was
confirmed using the isolates ST as determined by MLST.
MLST. Genotyping by 7-locus MLST was performed as
described previously [26]. Allele profiles and sequence types (ST’s)
were assigned using the Campylobacter MLST profile database
(PubMLST. Available: www.pubmlst.org. Accessed 2013 Oct 2.).
Clinical isolates from north-east Scotland. Isolates were
received on CCDA plates from Aberdeen Royal Infirmary. Single
colonies were plated on modified CCDA and incubated, genus
and species confirmed and typing by MLST were all carried out as
described above (See Table S1).
Epidemiological Data Analysis
Demographic time series analysis of Campylobacter
cases. This was performed at postcode sector (2000–2006,
npcs = 937) and health board level (1990–2006, nhb = 12 and 2007–
2011, nhb = 11). At postcode sector level urban cases were defined
as those with .200 persons/km2, otherwise defined as rural. The
incidence for both the rural and urban cases was calculated across
Scotland for each study year. From this the urban/rural ratio was
calculated along with the 95% binomial confidence intervals. At
health board level the total urban and rural populations were
determined using GROS data in ArcGIS 10.0 (ESRI, Redlands,
California, USA). The Campylobacter cases were designated as
urban or rural in proportion to the urban/rural population in each
health board. All urban designated cases were summed across
Scotland and divided by the urban population to obtain the urban
incidence. This was repeated for the rural cases. Finally the
urban/rural ratio and confidence intervals were calculated as
above and this was repeated for each year. This was also
performed by age group (0–4, 5–14, 15–64, 65+, see Table S2).
Case-case analysis. Two analyses were performed on
reported cases from the Grampian Region of Scotland. These
compared the lower incidence period (2002–2006, 3313 cases) and
the resurgence period (2007–2010, 2885 cases) with the peak
period (1997–2001, 4049 cases). Five parameters were available as
putative risk factors; (1) age (0–4, 5–14, 15–64, 65+), (2) gender
(male or female), (3) season (summer - June to August - or the rest
of the year), (4) rural or urban human population density (rural
#200 individuals/km2 and urban .200 individuals/km2) and (5)
deprivation - deprived (Carstairs index .23) or affluent (Carstairs
index #23) – see Table S3. Analyses were carried out using
univariate and multivariate logistic regression employing the
epidemiological modelling software package EGRET (version
2.0.3, Cytel Software Corporation, Cambridge, MA, USA).
Results for each risk factor were considered as statistically
significant when P,0.05. Factors from the univariate analyses
with a P value of ,0.25 were used in the multivariate analysis.
Molecular epidemiology
Nei’s genetic distance. Standardized genetic distances (d1)
between clinical and host sources for the periods 2001, 2005–07
and 2010–12 were determined using the method of Nei [36] and
applied to genetic locus data by the method of Manly [37]. The
level of significance was obtained using randomization tests
(10,000 iterations). Briefly, the data from the populations (e.g.
clinicals and chicken) were randomized in Excel using PopTools
(PopTools. Available: http://www.cse.csiro.au/poptools/. Ac-
cessed 2013 Oct 2.) and the genetic distance calculated. This
process was then repeated 10,000 times using the Monte Carlo
Excel add-in @RISK (Palisade Ivybridge, United Kingdom). The
posterior distribution of genetic distances was then compared with
the non- randomised genetic distance to obtain the level of
significance (P value).
Source attribution. The probable reservoir origin of Cam-
pylobacter was investigated using MLST sequence types (ST’s)
investigated with STRUCTURE genetic population software [38].
Using this method, isolates can be probabilistically assigned to
ancestral populations based on ST frequencies. Source datasets of
Campylobacter strains with known origins were used as a reference
population and clinical isolates were attributed to this based on ST
similarities (see Table S1). This source dataset comprised data
collected in three time periods 2001 (chicken (n= 84)), 2005–07
(chicken (n= 277), cattle (n = 104), sheep (n= 97), wild birds
(n = 188) and pigs (n = 40)) and 2010–12 (chicken (n= 354), cattle
(n = 158), sheep (n = 196)) obtained from the CaMPS study and it’s
extension i-CaMPS [39].
Genetic diversity. Genetic diversity was determined by
Simpson’s index [40] where a value of 0 indicates homogenous
ST’s and a value of 1 indicates a heterogeneous population with
maximum diversity. Confidence intervals were calculated using a
bootstrap method from the PopTools add-in for Microsoft Excel
(PopTools. Available: http://www.cse.csiro.au/poptools/. Ac-
cessed 2013 Oct 2.).
Geneaolgy of isolates. The clonal genealogy of Campylobacter
sequence types (ST’s) was estimated using the model-based
approach for determining bacterial microevolution employed in
CLONALFRAME, version 1.0 (Xavier Didelot. Available: http://www.
xavierdidelot.xtreemhost.com/clonalframe.htm. Accessed 2013
Oct 2.) [41]. This approach incorporates both point mutation
and horizontal gene transfer events. The program was run with
50,000 ‘‘burn-in’’ iterations which are discarded to minimise the
effects of initial values followed by 50,000 data collection
iterations. The consensus trees represent combined data from
three independent runs, with 75% consensus required for
inference of relatedness. Two trees were generated, one for C.
jejuni and the other for C. coli [42]. Due to the large datasets
singleton strains were removed (370 and 62 for C. jejuni and C. coli
respectively).
Results and Discussion
This comprises four sections. The first uses the explanatory
variables obtained from Morse’s emergence factors to give an
informed explanation of the different phases of the human
campylobacteriosis epidemic in Scotland. This involved four
phases (epidemic rise (1990–1999), peak (2000–01), fall (2001–
06) and resurgence (2007–11) during which there was a .300%
The Emerging Campylobacter Epidemic
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increase in disease incidence in the elderly and a 50% reduction in
young children (Figs. 1(a) and (b)). The second section describes
the CLONALFRAME results. The third gives an international
perspective and identifies limitations of the study. The fourth
considers future trends and the general utility of Morse’s factors for
disease emergence.
Explanation of the phases of emergence
Epidemic rise of human campylobacteriosis (1990–
1999). During this period the number of human cases increased
by 75% (Fig. 1(a)), hospitalisation rates were relatively high, the
poultry industry increased in size (Fig. 1(d)) by .18% and
availability of poultry meat provided a relatively inexpensive,
nutritious and healthy source of protein that the public readily
embraced [43]. This can be seen by the 10% increase of household
purchases during this period (Fig. 1(d)). The increase in human
cases took place across the country but was greatest in urban areas
(Fig. 1(i)). This latter fact is likely to be more consistent with an
increasing foodborne (e.g. chicken) source of infection. It has
already been established that rural cases of disease are more likely
to be associated with non-chicken (e.g. ruminant or wild bird)
genotypes [29]. This is especially the case for young children (,5
years) who are in effect sentinels of environmental infection
pressure. This is further emphasised by the static level of cases in
young children (Fig. 1(b)) during this period which provides further
evidence to show that the epidemic rise cannot be explained by
environmental sources and that a foodborne route (e.g. chicken) is
more probable.
The number of visits abroad increased by 60% during this
period. Assuming the same fraction of these resulted in acquiring
Campylobacter infections as reported in the case-control study [24],
9% of human cases are likely to be associated with travel abroad
throughout the 1990’s. PPI’s were first introduced in 1989 and
usage increased during the 1990’s [44]. By 1999 an estimated 6%
of cases were associated with PPIs and this includes 22% in the
elderly. It is recognised that gastric acidity is an important defense
mechanism against ingested pathogens, Campylobacter is sensitive to
acid stress [45] and PPI’s have also been associated with an
increase of other gastrointestinal infections including C. difficile
[46]. Ideally case-control information, molecular genotyping of
human cases and animal populations carried out during this
period would provide further evidence to identify and explain
changes in the putative sources of human campylobacteriosis.
A final explanation for the increase of Campylobacter cases during
this period could be due to enhanced awareness in public health or
a change in methods (e.g. at clinical diagnostic labs). However, this
seems unlikely for two reasons. The first, that the methodologies in
public health/microbiology labs did not change over this period
and the second that the ratio of community to reported
Campylobacter cases were not significantly different in the intestinal
infectious disease studies carried out between 1993–96 and 2008–
09 [9,47].
Peak period 2000–01. Human incidence peaks (Fig. 1(a)),
prevalence in chicken was high (81%) and both genetic distance
and source attribution indicate that retail poultry is the most
important source of human campylobacteriosis (Fig. 2). Further,
Simpson’s diversity index was indistinguishable between clinicals
and chicken (P.0.05). In addition, five out of the top ten clinical
and chicken ST’s were the same (Fig. 3 and Table S1). ST584 is
present in both humans (2.9%) and chicken (6%) but disappears in
subsequent years. The urban/rural incidence is also high (.1.0)
during this period suggesting that a food-borne rather than
environmental source is responsible.
Decline and trough 2001–06 (approx). There was a drop in
human incidence across all age groups (particularly striking in the
,5 year olds where there was a 35% fall) except the elderly (5%
increase). Hospitalisation rates were static during this period
(Fig. 1(a)). Molecular attribution indicates that chicken is still the
most important source of human disease but genetic distance
indicates that cattle and chicken are both important, whereas wild
birds and pigs are relatively unimportant. The dramatic fall of
35% in young children comprises a reduction of 5% and 53% in
rural and urban disease incidence respectively. It has already been
established [28] that environmental sources are important for
cases in young rural children and hence it seems likely that non-
foodborne routes of infection are still prominent throughout this
period. The case-case temporal study shows that for the overall
population the urban/rural ratio decreases in this period
compared with 1997–01 (Table 2, see also Fig. 1(i)). This is due
to the relatively high reduction in urban compared to rural
incidence suggesting that there could be a drop in cases associated
with chicken. This concurs with a significant increase (P,0.05) in
Nei’s genetic distance when comparing clinical and chicken
isolates between 2001 and 2005–07 and a decrease (although not
significant, P.0.05) in clinical isolates attributed to chicken
(Fig. 2.).The increase in the elderly may be explained by the
50% increase in dispensing of PPI’s as well as omeprazole
(Prilosec) becoming available over the counter in 2004 [48].
Despite human incidence decreasing, travel associated cases
increased by an estimated 5%. Also, household purchases of
poultry are still strong and the prevalence in chicken, though lower
than in 2001, is not significantly so (P.0.05). There is a change in
the distribution of genotypes over this period [34] (see Table S1)
which may play a role in explaining the changes in human disease:
genotypes may have different dose responses [49] and different
capacities to cause human morbidity [50].
Resurgence 2007–2011. There was a 20% increase in
human incidence which can be seen across all age groups and
particularly the elderly (50% increase) who also present a dramatic
100% increase in hospitalisations. The case-case study (Table 2)
also showed an increase in elderly cases compared with 1997–01
(OR=1.38, P,0.0001). PPI dispensing increased by 30%
(numbers of over the counter sales probably increased as well
though data are unavailable) and it is likely that .30% of cases in
the elderly were associated with PPI’s (Fig. 1(h)). Further, at least
one quarter of the increase in incidence during this period was
likely to be associated with PPIs (Fig. 1(h)). Although houshold
purchases of poultry decreased by 5% (Fig. 1(d)) the prevalence of
Campylobacter in chicken was highest (93%, P,0.01) (Fig. 2(c)).
Cattle and sheep also have high prevalence compared with the
previous period (P,0.0001), but source attribution and genetic
distance identify chicken as the most important putative source for
human disease. Further, since 2010 Campylobacter has become the
most frequent agent of foodborne outbreaks in England and Wales
[51]. The majority of these outbreaks are associated with chicken
liver paˆte´ or parfait and so the preference of lightly cooking could
well be contributing in part to the rise of cases seen in the human
population. ST5136 appears to be a new strain (only found in this
period Fig. 3(a)) and is associated with chickens and humans.
CLONALFRAME derived geneology
Clinical isolates are widely distributed across the C. jejuni
phylogenetic tree (Fig. 3(a)). To a lesser extent this is the case for
chicken and to an even lesser extent this is the case for cattle and
sheep. Some ST’s can be considered generalists and are found in
most hosts and time periods (e.g. ST21, ST53, ST48, also ST19,
ST61, ST42 (these are more common in cattle and sheep), also
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Figure 1. Time series data (a) incidence and hospital discharge rates of human campylobacteriosis in Scotland, (b) incidence
stratified by age, (c) hospitalisation rates stratified by age, (d) number of chicks placed into UK broiler farms and poultry purchases
by household, (e)–(h) age stratified incidence associated with foreign travel, use of proton pump inhibitors and the residual (not
explained by the former two factors) and (i) urban/rural ratio of incidence aggregated from Health Boards (1990–2011) and postal
sectors (2000–2006) with 95% binomial confidence intervals.
doi:10.1371/journal.pone.0079331.g001
Figure 2. Host prevalence (a)–(c), genetic distance between human clinical and host genotypes (d)–(f), source attribution by
STRUCTURE (g)–(i) and Simpson’s index of diversity (j)–(l) for the three time periods (2001, 2005–07 and 2010–12).
doi:10.1371/journal.pone.0079331.g002
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ST257 (more common in chicken) and ST45 (more common in
chicken and birds)). Further, some ST’s appear to be found only in
clinical and chicken isolates (ST51, ST354, ST574, ST5136). Pig
C. jejuni ST’s are rare and there is a cluster of wild bird sequence
types (see Fig. 3(a)) that are relatively rare in the other hosts.
Similar percentages of clinical 16% (29 present in all three
periods/180 present in at least one period) and chicken 14% (13/
93) non-singleton ST’s are present throughout the 3 time periods
of the study (P= 0.725). Cattle and sheep isolates were genotyped
during only two periods of the study (2005–07 and 2010–12) but it
was found that for non-singletons 40% (12/30) cattle and 43%
(16/37) sheep ST’s were present in both time periods.
Clinical, chicken, sheep and pig isolates are found across the C.
coli tree (Fig. 3(b)) whereas there are infrequent wild bird (n = 4 and
8 singletons) and cattle (n = 4 and 2 singletons) ST’s. Some
genotypes (e.g. ST825 (all), ST827 (all except pigs), ST1614 (all
except pigs and birds)) are found in most hosts for at least two of
the time periods. ST854 is common (15%) in pigs but rarely found
in clinicals and chicken. A number of ST’s (n = 5) are only found in
pigs.
International comparisons and study limitations
This analysis of the Campylobacter epidemic is likely to be
representative of the UK as a whole where there have been similar
changes in incidence [6]. Evidence exists from other countries on
changes in Campylobacter incidence rates over the last 25 years. For
example in New Zealand campylobacteriosis increased to a rate of
.350 per 100,000 prior to 2006 which was contemporaneous with
rising poultry consumption [30]. Human incidence fell by 50%
post-2006 coincident with a range of voluntary and regulatory
poultry interventions. This resulted in a 74% reduction in cases
attributed to poultry with a higher proportion of the remaining
cases being rural and associated with ruminants. In Iceland [52]
before 1996 all retail poultry was frozen as a control measure for
salmonellae, which coincidentally reduced Campylobacter loading
resulting in 10 cases per 100,000 of the population reported
annually. In 1996, fresh poultry was allowed to be sold and by
1999 the campylobacteriosis rate had risen to 120 per 100,000.
Subsequently, flocks were tested before slaughter and for those
that were found to be positive the birds were frozen prior to retail.
This intervention, together with on-farm measures, reduced the
incidence of human campylobacteriosis close to that found before
Figure 3. CLONALFRAME geneaologies for (a) C. jejuni and (b) C. coli for the three study periods. The abundance (%) of each genotype in each
host, for a particular time period, for combined C. jejuni and C. coli, is denoted by length of scale bar. Singleton ST’s were removed from the analysis.
doi:10.1371/journal.pone.0079331.g003
Table 2. Results of the logistic regression for the case-case studies.
Comparing 2002–06 (cases) versus 1997–01(Ref.
period)
Comparing 2007–10 (cases) versus 1997–01 (Ref.
period)
Factors Group O.R. C.I. (95%) P-value O.R. C.I. (95%) P-value
(A)Univariate
agea young 1b - - 1b - -
old 1.112 1.042–1.186 0.0013*{ 1.380 1.288–1.478 ,0.0001*{
gender male 1b - - 1b - -
female 0.931 0.49–1.020 0.1248{ 0.960 0.873–1.057 0.4083
season rest of year 1b - - 1b - -
summer 0.972 0.879–1.075 0.5799 0.885 0.796–0.984 0.0234*{
location rural 1b - - 1b - -
urban 0.895 0.815–0.982 0.0196*{ 0.937 0.850–1.033 0.1913
Carstairs affluent 1b - - 1b - -
deprived 0.914 0.833–1.002 0.056{ 0.929 0.845–1.024 0.1377
(B) Multivariate
agea young 1b - - 1b - -
old 1.215 1.051–1.197 0.0006* 1.380 1.285–1.476 ,0.0001*
season rest of year 1b
summer 0.898 0.807–1.000 0.0491*
location rural 1b - -
urban 0.880 0.801–0.967 0.0077*
(A) Odds ratios and their associated P-value for all the selected cases in the univariate models.
*Factors with P,0.05 are considered as significant.
{Factors with a P,0.25 are entered in the multivariate model.
(B) Odds ratios and P-values for the final multivariate models. Previous steps, consisting in removing one by one the factors with the highest P-value at each step, are
not shown. The program used to execute the analysis gave P = 0.002 for the overall model fit comparing 2002–06 with 1997–01 and P=,0.0001 comparing 2007–10
with 1997–01.
aHumans are grouped into four age groups with the reference group being young children (0–4 years) (see Table S2) and the odds ratio indicates the relative amount by
which the odds of the outcome changes when the value of the predictor value is increased by 1.0 unit.
bReference group.
doi:10.1371/journal.pone.0079331.t002
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1996 [53]. In the USA, campylobacteriosis has fallen by 27% since
1996 [8]. Most of this change was between 1996–2001, and this is
thought to be primarily due to improved sanitation in broiler
processing, particularly the addition of chlorine in the spin chiller,
an intervention that was also used in New Zealand.
Elucidating the past aetiology of epidemics is by necessity an
incomplete science since it is attempting to infer history from
partial datasets utilising methods from a number of scientific
disciplines (e.g. microbiology, epidemiology, molecular biology etc)
that are still under development. For example the case-control
study in NE Scotland [24] did not investigate specific risk factors
for chicken (e.g. undercooking or eating chicken at a restaurant)
which would have provided valuable information to the current
study. However, data on consumption of chicken together with
genotyping data (e.g. source attribution and Nei’s genetic distance)
provided information on exposure at a population level and likely
reservoir source of disease. Other risk factors which were not
possible to include in the temporal analysis across the study
included drinking unpasteurised milk, recreational water exposure
and drinking water from a private water supply. The sale of
unpasteurised milk and cream has been banned in Scotland since
1983 and so there are unlikely to be many cases of campylo-
bacteriosis via this vehicle. The only recreational water exposure
risk factor of statistical significance from the NE Scotland case-
control study was diving in the sea. However, this comprised only
a few individuals and although this may be an important risk
factor for this group it is likely to have little impact on the total
number of cases of campylobacteriosis. Consumption of water
from private water supplies was found to be of significance in the
NE case-control study conducted during 2005–07. It is unknown
how disease associated with this risk factor may have changed over
time but it is known that there have been a number of initiatives
and grants to improve private water supplies in Scotland (e.g.
treatment by UV light).
It was possible to combine the PPI and foreign travel case-
control data from NE Scotland with national time series data for
PPI dispensing rates and foreign travel visits respectively to infer
the associated disease burden throughout the study period. This
assumed that there would be no confounding when scaling from
region to nation. It has been previously shown that there is no
significant difference between the distribution of clinical Campylo-
bacter genotypes between regions and nationally [39]. However,
national case control data on the risk factors would validate the
results presented here and provide information at the level of the
individual which would complement our inferences made at the
level of the population.
There is also the potential for reporting bias which can suggest
that there are changes in disease incidence (e.g. over time, between
age groups, between urban and rural populations etc) when in
reality there are none. However, post 1990 in Scotland there have
been no changes in public health policy and clinical lab
diagnostics. Also, similar changes in overall disease incidence, as
well as disease incidence stratified by age, have been reported for
England and Wales [16].
It is clear that collections of genotyped human and animal
isolates combined with risk factors from case-control (or/and case-
case) studies and time series data sets are required across the
period under study. This of course requires signficant financial
resources which must be set against competing requirements (from
other infectious diseases and elsewhere) from public health, food
safety and other governmental agencies. However, a coordinated
approach is required to hasten understanding of a pathogen such
as Campylobacter which is an issue across the world and this is
currently lacking.
Predicting the future and determining the utility of
Morse’s factors for infectious disease emergence
This paper has provided explanations of what has happened in
the past. Of greater importance is to apply this knowledge to
predict what may happen in the future and to act on this by
developing strategies to reduce the burden of disease. It is
therefore important to understand how Morse’s factors for disease
emergence may change. In terms of ecological changes due to
economic/agricultural developments it is unlikely that there will be
further intensification in poultry production in the developed
world and only modest increases are forecast for the UK and USA
over the next ten years [54]. There seems to be little scope for
controlling Campylobacter in the wider agricultural environment
because of its many domestic and wildlife reservoirs.
Human demographics will change in the developed world with
an increasingly elderly population. For example in Scotland
between 2010 and 2020 it is estimated that there will be 15% and
23% increases in the 60–74 and 75+ age groups respectively. This
could lead to both a 7% and 5% increase in hospitalisations and
reported cases respectively (assuming everything else is held
constant). PPI dispensing still appears to be increasing and this
combined with the growing numbers of elderly will likely result in
further increases in cases and hospitalisations. However, a recent
study [55] indicates that PPIs are a marker for human
campylobacteriosis and other factors must be responsible for the
increased risk in this cohort. There is the potential for human
behaviour to change. For example attitudes to Campylobacter from
regulatory and industry are changing. There is a recognition by
industry that Campylobacter contamination is a problem that needs
to be dealt with (British Poultry Council. Available: www.
britishpoultry.org.uk/?p = 1857. Accessed 2013 Oct 2.). In the
UK, the EU and elsewhere government led strategies are being
developed and research carried out to try to reduce the prevalence
and loading of Campylobacter in chicken [56]. It is not yet possible to
assess how successful these will be.
International travel has reduced during the recent recession
(2008–9 and 2011–12). It is of course very difficult to predict
economic recovery but when this does take place then interna-
tional travel will increase and it is likely that human campylo-
bacteriosis will increase as a result. Technology and industry
developments include development of poultry breeds that are
resistant to Campylobacter or a vaccine [57]. However, these
solutions appear to be at least 5–10 years away.
There is the likelihood of microbial adaption and change in the
population of Campylobacter. This has already been seen in
changing genotypes and the appearance and disapperance of
particular ST’s found in humans and poultry. There is also
concern of increasing antimicrobial resistances in human isolates
(e.g. 30% increase in ciprofloxacin resistance between 1995 and
2008 largely caused by veterinary application in agriculture [58]).
Improved public health measures (e.g. improving kitchen hygiene
in both commercial and domestic premises and proper cooking of
chicken liver paˆte´) can be readily attempted through education.
However, again it will be difficult to gauge the potential success of
these.
All of the six emergence factors considered (Table 1) play a role
in the changing Campylobacter epidemic, demonstrating the
multifactorial nature of this infectious disease. The relative
importance of these factors is confounded by interactions between
them (e.g. ecological change through intensification of chicken
production has offered greater potential for Campylobacter to reach
humans whose risk of infection is exacerbated if they are being
prescribed proton pump inhibitors). Currently there is no general
theory for the emergence of an infectious disease that can
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encompass the myriad of factors (many of which are interacting)
associated with this process. There is both germ theory and
evolutionary theory which both have explanatory powers and
contribute to understanding [59]. However, for Campylobacter even
the utility of evolutionary theory is limited as far as humans are
concerned because of the rarity of secondary transmission. There
is the potential of using mathematical models to improve
understanding of the epidemic. This would most likely require
some combination of agent based (where the agents are the hosts)
and spatially explicit contact network methods [60]. This has yet
to be attempted but these types of models provide the opportunity
to better understand the processes in disease transmission and the
potential to simulate interventions.
In conclusion, Morse’s emergence factors are demonstrated
here to be of utility as a framework unravelling the aetiology of
human campylobacteriosis [1]. It has been shown that these
factors, made specific for Campylobacter (Table 1), can be both
elucidated further and quantified through a series of explanatory
variables (e.g. time series data and risk factors). Although, as
admitted by Morse, the exact selection and wording of these
emerging factors can be thought of as arbitrary and how they can
be made operational is open to interpretation by the individual
researcher, they do show promise across a gamut of emerging
infectious diseases. Until a more parsimonious paradigm or
framework can be established they are still a valuable tool in
studying the emergence and re-emergence of infectious diseases.
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